Tollefson MK - Search Results

1

Predictors of Locoregional Recurrence and Delineation of Adjuvant Radiation Therapy Fields for Patients With Upper Tract Urothelial Carcinoma Receiving Nephroureterectomy.

Gao RW, Tollefson MK, Thompson RH, Potretzke AM, Quevedo FJ, Choo R, Davis BJ, Pisansky TM, Harmsen WS, Stish BJ. Gao RW, et al. Among authors: tollefson mk. Pract Radiat Oncol. 2021 Sep-Oct;11(5):e468-e476. doi: 10.1016/j.prro.2021.02.005. Epub 2021 Feb 23. Pract Radiat Oncol. 2021. PMID: 33636378

2

Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other.

Tollefson MK, Thompson RH, Sheinin Y, Lohse CM, Cheville JC, Leibovich BC, Kwon ED. Tollefson MK, et al. Cancer. 2007 Aug 15;110(4):783-90. doi: 10.1002/cncr.22840. Cancer. 2007. PMID: 17594714 Free article.

3

Significance of distal ureteral margin at radical cystectomy for urothelial carcinoma.

Tollefson MK, Blute ML, Farmer SA, Frank I. Tollefson MK, et al. J Urol. 2010 Jan;183(1):81-6. doi: 10.1016/j.juro.2009.08.158. J Urol. 2010. PMID: 19913820

4

Peering through the microscope lens into the future.

Tollefson MK, Thompson RH. Tollefson MK, et al. Eur Urol. 2010 Nov;58(5):669-70. doi: 10.1016/j.eururo.2010.08.046. Epub 2010 Sep 15. Eur Urol. 2010. PMID: 20846782 No abstract available.

5

Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence.

Boorjian SA, Thompson RH, Tollefson MK, Rangel LJ, Bergstralh EJ, Blute ML, Karnes RJ. Boorjian SA, et al. Among authors: tollefson mk. Eur Urol. 2011 Jun;59(6):893-9. doi: 10.1016/j.eururo.2011.02.026. Epub 2011 Feb 22. Eur Urol. 2011. PMID: 21388736

6

Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival.

Boorjian SA, Tollefson MK, Cheville JC, Costello BA, Thapa P, Frank I. Boorjian SA, et al. Among authors: tollefson mk. J Urol. 2011 Nov;186(5):1796-802. doi: 10.1016/j.juro.2011.07.005. Epub 2011 Sep 25. J Urol. 2011. PMID: 21944088

7

High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma.

Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH. Wang JK, et al. Among authors: tollefson mk. Urology. 2012 Mar;79(3):615-9. doi: 10.1016/j.urology.2011.11.049. Urology. 2012. PMID: 22386411

8

Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease.

Tollefson MK, Boorjian SA, Farmer SA, Frank I. Tollefson MK, et al. World J Urol. 2012 Dec;30(6):795-9. doi: 10.1007/s00345-012-0855-8. Epub 2012 Mar 25. World J Urol. 2012. PMID: 22447397

9

Hospitalization costs for radical prostatectomy attributable to robotic surgery.

Kim SP, Shah ND, Karnes RJ, Weight CJ, Shippee ND, Han LC, Boorjian SA, Smaldone MC, Frank I, Gettman MT, Tollefson MK, Thompson RH. Kim SP, et al. Among authors: tollefson mk. Eur Urol. 2013 Jul;64(1):11-6. doi: 10.1016/j.eururo.2012.08.012. Epub 2012 Aug 20. Eur Urol. 2013. PMID: 22959352

10

Natural history of biochemical recurrence after radical prostatectomy with adjuvant radiation therapy.

Boorjian SA, Tollefson MK, Thompson RH, Rangel LJ, Bergstralh EJ, Karnes RJ. Boorjian SA, et al. Among authors: tollefson mk. J Urol. 2012 Nov;188(5):1761-6. doi: 10.1016/j.juro.2012.07.037. Epub 2012 Sep 19. J Urol. 2012. PMID: 22998913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166 results

Search Page